Trial Profile
Phase IIb trial of tumour necrosis factor alpha kinoid for Crohn's disease planned.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2012
Price :
$35
*
At a glance
- Drugs Tumour necrosis factor-alpha kinoid (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 09 Jun 2012 New trial record